Type 2 diabetes
Item
subjects with type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Duration of insulin treatment
Item
subjects with insulin treated for at least 24 weeks
boolean
C0444917 (UMLS CUI [1,1])
C0745343 (UMLS CUI [1,2])
Hba1c
Item
hba1c maximum 11.0%
boolean
C0019018 (UMLS CUI [1])
Body mass index
Item
body mass index (bmi) below 30.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Self-injection of insulin and self-monitoring blood glucose
Item
patients who have the skill of self-injection of insulin, and are able and willing to perform self-monitoring blood glucose (smbg) and are able to take measures against hypoglycaemic episodes
boolean
C3880392 (UMLS CUI [1,1])
C0745343 (UMLS CUI [1,2])
C0005803 (UMLS CUI [2])
Recurrent severe hypoglycaemia
Item
recurrent severe hypoglycaemia
boolean
C0342316 (UMLS CUI [1])
Ophthalmological status
Item
subjects with proliferative retinopathy or preproliferative retinopathy diagnosed within the last 12 weeks, or receiving photocoagulation therapy within the last one year
boolean
C0339467 (UMLS CUI [1])
C0339473 (UMLS CUI [2,1])
C2316983 (UMLS CUI [2,2])
C0023694 (UMLS CUI [3,1])
C2584899 (UMLS CUI [3,2])
Hepatic function
Item
impaired hepatic function
boolean
C0232741 (UMLS CUI [1])
Renal function
Item
impaired renal function
boolean
C0232804 (UMLS CUI [1])
Cardiac diseases
Item
cardiac diseases
boolean
C0018799 (UMLS CUI [1])
Uncontrolled hypertension
Item
uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1])
Allergies and Hypersensitivity reactions
Item
subjects with history of severe allergic or severe hypersensitive reactions
boolean
C0020517 (UMLS CUI [1])
Daily insulin dose
Item
total daily insulin dose at least 100 iu
boolean
C2348070 (UMLS CUI [1,1])
C0557978 (UMLS CUI [1,2])
Oral hypoglycaemic agents
Item
treatment with oral hypoglycaemic agents within the last 4 weeks
boolean
C0359086 (UMLS CUI [1,1])
C1531783 (UMLS CUI [1,2])